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Abstract
Background: Initiation of eukaryotic DNA replication involves many protein-protein and protein-
DNA interactions. We have previously shown that 14-3-3 proteins bind cruciform DNA and
associate with mammalian and yeast replication origins in a cell cycle dependent manner.
Results: By expressing the human 14-3-3ε, as the sole member of 14-3-3 proteins family in
Saccharomyces cerevisiae, we show that 14-3-3ε complements the S. cerevisiae Bmh1/Bmh2 double
knockout, conserves its cruciform binding activity, and associates in vivo with the yeast replication
origins ARS307. Deletion of the α5-helix, the potential cruciform binding domain of 14-3-3,
decreased the cruciform binding activity of the protein as well as its association with the yeast
replication origins ARS307 and ARS1. Furthermore, the mutant cells had a reduced ability to stably
maintain plasmids bearing one or multiple origins.
Conclusion: 14-3-3, a cruciform DNA binding protein, associates with yeast origins of replication
and functions as an initiator of DNA replication, presumably through binding to cruciform DNA
forming at yeast replicators.
Background
Several studies have shown that cruciform DNA forms at
or near eukaryotic origins of replication and is involved in
the regulation of initiation of DNA replication [1,2]. In
mammalian cells, cruciform extrusion is cell cycle regu-
lated and reaches a maximum at the G1/S boundary [3].
The formation of cruciform DNA has also been shown in
the Saccharomyces cerevisiae replication origin ARS307 [4],
as revealed by specific anti-cruciform DNA monoclonal
antibodies (mAbs) [5,6]. These mAbs have an enhancing
effect on DNA replication, presumably through stabiliza-
tion of cruciform structures forming at replication origins,
which may function as recognition sites for the binding of
regulatory proteins of DNA replication [1].
We previously purified from human (HeLa) cells a cruci-
form-specific binding protein, CBP [7] which was identi-
fied by sequence analysis as a member of the highly
conserved 14-3-3 protein family [8]. The 14-3-3 proteins
are mono- and hetero-dimeric molecules, conserved
through plants, invertebrates, and higher eukaryotes
(reviewed in [9]). There are at least seven distinct 14-3-3
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genes in vertebrates giving rise to nine isotypes (α, β, γ, δ,
ε, ζ, η, σ, and τ, with α and δ being phosphorylated forms
of β and ζ, respectively), while at least another twenty
have been identified in yeast, plants, amphibians and
invertebrates (reviewed in [10]). The 14-3-3 proteins are
implicated in multiple cellular processes including signal-
ling, cell cycle control, apoptosis, transcription and DNA
replication (reviewed in [10-12]).
In mammalian cells, CBP activity occurs only when 14-3-
3 is in a dimeric form [8]. Hydroxyl radical footprinting
analysis localized the interaction of CBP with cruciform
DNA to the four-way junction [13], conforming to the
crystal structure of 14-3-3 [14,15], whereby the 14-3-3
dimers form a groove which provides the cruciform bind-
ing domain [13]. A similar interaction with the cruciform
DNA has been found for the anti-cruciform monoclonal
antibody 2D3 [16], suggesting the involvement of a com-
mon specific domain in both the 2D3 antibody and the
14-3-3 protein. Alignment of 2D3 antibody and 14-3-3ε
sequences revealed two domains of homology within the
N-terminal residues of 14-3-3 protein, with 40% similar-
ity for positive residues in the α5-helix (data not shown).
This domain is conserved in all 14-3-3 homologues and is
located in the amphipathic groove, which is involved in
nearly all the interactions of 14-3-3 with its protein part-
ners [17], as well as in the binding to cruciform DNA [13].
In addition to its cruciform binding activity, CBP/14-3-3
was also shown to bind to mammalian replication origins
in a cell cycle dependent manner, reaching a maximum at
the G1/S boundary [18,19]. The role of 14-3-3 in DNA
replication, through direct association with replication
origins, has not been determined yet. Proteomic analysis,
however, indicated that 14-3-3 interacts with replication
initiator proteins such as MCM3, Ku antigen [20,21] and
MCM10 [22], implicating 14-3-3 in the regulation of ini-
tiation of DNA replication. The function of 14-3-3 pro-
teins as a major regulator of the cell cycle has been
reported in many studies. Thus, 14-3-3s regulate the cell
cycle progression by sequestrating cell cycle proteins, like
CDC25C [23] and p27 [24,25] in the cytoplasm. It has
been also shown that 14-3-3 proteins have a temporal role
in G1 arrest and S-phase checkpoint function [26].
The involvement of 14-3-3 in DNA replication has also
been demonstrated in lower eukaryotes. In Saccharomyces
cerevisiae, Bmh1 and Bmh2, the budding yeast 14-3-3
homologues [27,28], also bind to cruciform DNA and
associate in vivo with origins of replication [4]. In a recent
study, 14-3-3 was also shown to be regulating the G1/S
transition in the budding yeast (S. cerevisiae), thus impli-
cating it in the initiation of DNA replication [29]. The
nature of replication origins (replicators) and the proteins
that interact with them are key to understanding the
mechanism regulating this process, which is conserved
among lower and higher eukaryotes [30]. The replication
origins of budding yeast cells have been well-character-
ized and used extensively to study the regulation of DNA
replication. Furthermore, the genetic manipulations
afforded by the yeast cells have made them very useful as
host organisms to investigate the function of various pro-
teins.
Taking advantage of these properties, here we analyzed
the function of the human 14-3-3ε protein, as the sole
member of 14-3-3 in the S. cerevisiae cells, in terms of its
cruciform binding activity and involvement in the initia-
tion of DNA replication. The human 14-3-3ε protein has
more than 60% sequence similarity at the amino acid
level with the budding yeast 14-3-3 protein homologues,
Bmh1 and Bmh2. Deletion the α5-helix in 14-3-3ε, as a
potential cruciform binding domain, resulted in a mark-
edly reduced yeast cell growth, as well as a decrease in cru-
ciform binding activity and in the association of 14-3-3
with the yeast replication origins ARS307 and ARS1. Fur-
thermore, the mutant cells showed a reduced ability to
stably maintain plasmids bearing one or two origins.
These results suggest that 14-3-3 is regulating DNA repli-
cation at the initiation level.
Results
Expression of the wild-type and α5-deleted human 14-3-3ε 
proteins in bmh1-bmh2 double knockout yeast cells
The S. cerevisiae strain (GG1259), containing a genetic
deletion of both the Bmh1 and Bmh2 proteins, is not via-
ble. The viability of this strain is supported by the 14-3-3
Arabidopsis thaliana homologue protein, GF14, under the
control of the inducible GAL1 promoter [31]. The wild-
type and mutant (α5-helix deleted) human 14-3-3ε
cDNAs were introduced in GG1259 cells, carried by the
pEVP11-URA vector. This vector contains the constitutive
ADH promoter, whose expression is increased in media
containing glucose as a carbon source. The genomic uracil
cassette in the GG1259 strain was removed to allow selec-
tion of pEVP11-URA+ clones. The new strains expressing
the wild-type 14-3-3ε (14-3-3ε) or α5-helix-deleted 14-3-
3ε (14-3-3-α5) respectively, as the sole members of 14-3-
3 proteins, were obtained by shuffling the plasmid carry-
ing the GF14 gene.
As shown in Figure 1A, both the wild type and mutant
strains, heretofore named 14-3-3ε and 14-3-3-α5 respec-
tively, were viable, indicating that both the wild-type and
the α5-helix-deleted 14-3-3ε complemented the S. cerevi-
siae bmh1-bmh2 double knockout. This strain (GG1259)
can be complemented by several plant and human 14-3-3
homologues, some of which complement well and some
very poorly [32]. The cells with GF14 alone (GG1259),
named Gal GF14, on the other hand, were unable to growBMC Molecular Biology 2007, 8:27 http://www.biomedcentral.com/1471-2199/8/27
Page 3 of 16
(page number not for citation purposes)
in YPD media (Fig. 1A), ruling out the possibility of the
participation of GF14 protein in the cell growth. As a pos-
itive control, Bmh1-Bmh2 wild type cells, named Bmh1/
2, were used to verify the yeast cell growth in normal con-
ditions (Fig. 1A). To determine the effect of the mutation
on cell cycle progression, both the wild type and mutant
strains were grown in YPD and CSM-Trp (synthetic com-
plete medium lacking tryptophan) media at 30°C. In
YPD, the mutant grew more slowly than the wild type
strain. This slower growth was more pronounced in the
selective (CSM-Trp) media (data not shown). The dele-
tion of α5-helix in 14-3-3ε conferred a slow-growth phe-
notype to the mutant cells compared to wild type, as seen
when the cells were grown in YNB media, spotted onto
YNB-Trp plates in 10-fold serial dilutions, and incubated
at 30°C (Fig. 1B).
Having established that the viability of the yeast cells can
be fully or partially supported by the wild type or the
mutant (α5-deleted) 14-3-3ε respectively, we checked for
the presence of these two proteins by western blotting
with anti 14-3-3ε antibody (T16; Santa Cruz biotechnol-
ogy) (Fig. 2A). Surprisingly, both the wild type and
mutant 14-3-3ε were detected by this antibody at the posi-
tion of 30 kDa, indicating that the mutant migrated simi-
larly to the wild type, in spite of the fact that it is lacking
20 amino acids of the α5-helix. A second band of 35 kDa
was typically detected by the anti-14-3-3ε antibody, as
also previously observed [8,18]. To rule out the possibility
that the anti-14-3-3ε antibody recognized a protein other
than the recombinant human 14-3-3ε in the yeast back-
ground, yeast strains expressing the Bmh1/2 proteins or
GF14 protein, were also used as controls (Fig. 2A). Only
one of the two yeast 14-3-3 homologues was detected by
the anti-human 14-3-3ε antibody, with the same pattern
as the human 14-3-3ε, while the GF14 protein was not
detected at all. In contrast, when an antibody against
Bmh1 protein [4,33] was used in the same blot, both
Bmh1 and Bmh2 proteins were detected (Fig. 2A, lower
panel, lane Bmh1/2), while only one band was detected in
yeast strains expressing the wild type and mutant 14-3-3ε
(Fig. 2A, lower panel, lanes ε and ε-α5). This antibody
also recognized the GF14 protein (Fig 2A, lower panel,
lane GF14), in contrast with the anti human antibody.
However, the 2 bands observed in GF14 are present in this
protein even when it is blotted with anti-GF14 antibody,
as detected in previous studies [4,34]. Thus, these bands
are different from Bmh1 and Bmh2, since these 2 proteins
are knocked-out in GF14 strain.
We examined next whether the observed growth defect
was due to less expression or degradation of the mutant
protein. It was recently reported that a cell growth defect
in mutant yeast 14-3-3 was associated with a temperature
sensitive (ts) phenotype [29]. A similar finding, however,
was not observed for the mutant 14-3-3ε in this study
(data not shown), which prompted us to verify the
amount of 14-3-3ε present in growing (log-phase) cells.
Whole cell extracts (WCE) from 107 cells (OD600 of 1.0),
were subjected to western blot analysis by immunoblot-
ting with anti-14-3-3ε antibody. The wild-type and
mutant proteins were similarly expressed (Fig. 2B,C), sug-
gesting that the mutation did not affect the expression
level of this protein, and that any other observed effect in
the mutant cells would be specifically functional. Further-
more, since 14-3-3 proteins associate with multiple pro-
tein partners as well as with cruciform DNA, we verified
whether these associations affected the affinity of the
anti14-3-3ε antibody for the protein. WCE from formal-
dehyde-fixed cells were also subjected to western blotting
(Fig. 2B), and quantification of the bands showed (Fig.
2C) that formaldehyde treatment had no effect on the
amount of 14-3-3 present in the extracts.
Effect of α5-helix deletion in 14-3-3ε on cruciform-binding 
activity
Since both the wild-type and the α5-helix-deleted human
14-3-3ε support the viability of the yeast cells, we ana-
lyzed whether 14-3-3ε protein, when expressed in yeast,
conserved its cruciform binding activity and whether dele-
tion of its potential cruciform domain affected this activ-
ity. Comparative band-shift analyses (Fig. 3A), using
whole cell extracts from cells expressing either wild-type
(lane 2) or mutant (lane 3) 14-3-3ε, indicated that the
mutant 14-3-3ε protein had a decreased mobility shift
compared to the wild-type. To verify the presence of 14-3-
3ε in the band-shifted complexes, the proteins were eluted
(see Methods) and analyzed by western blotting, using the
anti-human 14-3-3ε antibody. As expected, both the wild-
type and mutant 14-3-3 proteins were detected (Fig. 3B),
with both the major 30 kDa and the less intense 35 kDa
bands being present, as always detected by the anti-14-3-
3ε antibody [8,19].
Because the mutation in 14-3-3ε is the sole difference
between the two cell extracts, and the fact that 14-3-3
binds physically [8] and specifically [13] to cruciform
DNA, the data also suggest that α5-helix is only partially
responsible for the cruciform binding activity, since its
deletion did not completely abolish it. The reduction in
the mobility shift might not be attributable to the shorter
length of the deleted protein, as also shown previously in
similar studies [35,36]. However, to better characterize
the binding of 14-3-3ε to cruciform DNA, we performed a
protein concentration curve (Fig 3C). The results show
that for both the wild type and the mutant proteins, the
shifts are protein concentration dependent and propor-
tional to the amounts of the proteins added. Nevertheless,
for any amount of total proteins used, the band shift pro-
duced by the mutant strain extract is lower than the wildBMC Molecular Biology 2007, 8:27 http://www.biomedcentral.com/1471-2199/8/27
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Growth profile of wild-type and mutant 14-3-3ε proteins Figure 1
Growth profile of wild-type and mutant 14-3-3ε proteins. A- The strains expressing wild type 14-3-3ε protein (14-3-
3ε), mutant 14-3-3ε protein (14-3-3-α5), GF14 protein (GalGF14) and BY427 expressing Bmh1 and Bmh2 proteins strain 
(Bmh1/2) (used as a positive control), were streaked on a YPD plate and incubated at 30°C for 3 days. B- Cells were grown in 
YNB media, spotted onto YNB-Trp plates in 10-fold serial dilutions, and incubated at 30°C.
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Western blot analysis of wild-type and mutant 14-3-3ε proteins Figure 2
Western blot analysis of wild-type and mutant 14-3-3ε proteins. A- Whole cell extracts (WCE) of the wild-type(14-3-
3ε), the α5-helix-deleted (14-3-3-α5) 14-3-3ε, as well as Bmh1/Bmh2 and GF14 proteins-expressing cells, were prepared and 
20 μg of total protein of each were subjected to electrophoresis on a 12% SDS polyacrylamide gel. All proteins were revealed 
by probing with anti-14-3-3ε antibody and anti-Bmh1 antibody. B- Expression of the wild type and the mutant 14-3-3ε in the 
presence and absence of formaldehyde, detected by anti-14-3-3ε antibody. C- Quantification of the immunoblots after normal-
ization for the formaldehyde crosslinked 14-3-3ε.
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type, suggesting that the deletion of the α5-helix in 14-3-
3ε is responsible for this reduction.
It has been previously shown that CBP/14-3-3 recognizes
and binds to cruciform DNA specifically by structure
rather than sequence [4,7]. To verify the specificity of the
binding to cruciform DNA by the yeast-expressed 14-3-3ε,
competitive band-shift assays were performed, using
increasing amounts of cold cruciform or cold linear DNA
to compete with the labelled cruciform in the binding
reaction, as previously described [7]. As shown in Figures
3D and 3E, the mobility shift of the cruciform-14-3-3ε
complex decreased progressively with higher molar excess
of cold cruciform competitor, and was nearly completely
abolished at a molar excess of 500 × (Fig. 3D), while up to
2000 × of cold linear DNA did not compete with the cru-
ciform complex formation (Fig. 3E).
Furthermore, to determine whether the inhibition of the
cruciform binding activity in the mutant protein might be
due to a disruption of the site involved in the interactions
of 14-3-3 with its protein partners, which is located in the
groove [17], we analyzed the effect of addition of the 14-
3-3 peptide inhibitor, R18 (Biomol International, LP) on
the 14-3-3ε expressing yeast extract. In mammals, R18
binds with the same affinity to all 14-3-3 isoforms and
disrupts their substrate binding [37]. A concentration of
25 μM of R18 has been shown to inhibit the interaction of
14-3-3 proteins with their proteins partners in HeLa cells
extract [38]. However, since there is no previous character-
Cruciform-binding activity of 14-3-3ε Figure 3
Cruciform-binding activity of 14-3-3ε. Band shift assays were carried out as described in Methods. A- 3 ng of 32P-labelled 
cruciform DNA was incubated in the presence of 20 μg of wild-type (lane2) or mutant (lane 3) total whole cell extracts. Free 
cruciform DNA denotes the position of the probe alone. B- Western blot of proteins eluted from band-shifts initially per-
formed with 300 ng of labelled cruciform DNA, and probed with anti-14-3-3ε antibody (see Methods). C- Representative pro-
tein concentration curve using increasing amounts of total WCE containing wild type or mutant 14-3-3ε proteins incubated 
with 3 ng of cruciform DNA. Differences of migration rates of the shifted complexes with free cruciform DNA are repre-
sented with arbitrary units. D-E- Competition binding assays were carried out as described in Methods. Cold cruciform DNA 
(D) and cold linear DNA (E) competitors were added in the indicated amounts in a reaction with wild type 14-3-3ε. Free cru-
ciform DNA denotes the position of the probe alone.
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ization of the effect of R18 in yeast extract, we analysed the
ability of this inhibitor to disrupt the interaction of 14-3-
3ε with Ras2 protein, a known 14-3-3ε binding partner
[39]. The results show clearly that the yeast Ras2 protein
immunoprecipitates with 14-3-3ε in the absence of R18,
as indicated in the western blot by the band at 40 kDa,
while this band is completely absent after addition of 100
μM of R18 (Fig. 4A). WCE from a Bmh1/2 expressing cells
was used as a positive control. These data suggest that R18
functions in yeast as an inhibitor of 14-3-3 interactions, in
the same way as in mammalian cells.
Based on these results, we next analyzed the binding activ-
ity of the wild-type 14-3-3ε in the presence and absence of
R18. Even after using an excess amount (up to 100 μM) of
R18 in the cruciform binding assay, band shift analyses
showed that the cruciform binding activity of 14-3-3ε is
not affected by R18 treatment (Fig. 4B). Addition of very
high concentration of R18 (100 μM) resulted in higher
intensity of the same complex seen in the absence of R18
(Fig. 4B, last lane). These data suggest that 14-3-3ε binds
to cruciform DNA even when its protein binding site is
inhibited by R18 peptide, ruling out the possibility that
another 14-3-3 partner is involved in this activity. Thus,
overall the data suggest that the reduced cruciform bind-
ing activity of the mutant 14-3-3ε is specifically related to
the deletion of the α5-helix.
Association of wild-type and α5-helix deleted 14-3-3ε with 
yeast replication origins
The budding yeast (S. cerevisiae) replication origin
ARS307 has been well characterized [40,41]. Among other
DNA sequence features, it contains an inverted repeat
(IR), which extrudes into a cruciform structure, as shown
by immunoprecipitation (IP), using the specific anti-cru-
ciform DNA monoclonal antibody, 2D3 [4]. Since both
wild type and mutant 14-3-3ε proteins support the viabil-
ity of the budding yeast strains, we examined their associ-
ation with the replication origin ARS307 by the chromatin
immunoprecipitation (ChIP) assay, using formaldehyde
cross-linking and immunoprecipitation with anti-14-3-3ε
antibody or normal rabbit serum (NRS), as previously
described [4,19]. Extracts from wild type and mutant yeast
strains containing the same amount of total protein (1
mg), were subjected to immunoprecipitation using anti-
14-3-3ε antibody. The western blot (W.B) shows that in
both IPs, the antibody precipitated approximately the
same amount of 14-3-3ε (Fig. 5A), while NRS failed to
immunoprecipitate it. A WCE containing only 14-3-3ε
was used as a positive control (Fig. 5A). These results val-
idated the ChIP assays and have been used as control for
the quantification of the immunoprecipitated DNA. The
obtained ChIP materials were subjected to conventional
PCR using primers specific for ARS307. The results show
that for the anti-14-3-3ε antibody ChIP, an expected 370-
bp ARS307 fragment was amplified (Fig. 5B, lane 1, upper
and bottom panels, respectively). In contrast, PCR ampli-
fication of the chromatin that was immunoprecipitated by
the pre-immune serum, did not produce this fragment
(Fig. 5B, lane 2, upper and bottom panels, respectively),
confirming the specificity of the amplification, whereas
use of WCE from the 14-3-3ε wild type (lane 3, upper
panel) and the mutant (lane 3, bottom panel) strains, or
of S. cerevisiae genomic DNA (lane 4, upper and bottom
panels, respectively) as template DNA did. The plasmid
pRS306, containing ARS307 cDNA (lane5, upper and bot-
tom panels, respectively), was used as an additional posi-
tive control of the PCR reactions. These data showed that
the human 14-3-3ε protein, like its yeast homologues, can
associate with the yeast replication origin, ARS307, and
indicated the universality of the origin binding activity of
14-3-3 proteins.
To better analyze the effect of the α5-helix deletion in 14-
3-3ε on its ability to bind to replication origins, the
amount of origin-containing immunoprecipitated chro-
matin was quantified by Real-time PCR using two differ-
ent origins (ARS307 and ARS1) and their respective
negative regions (Neg307 and R2.5). Cross-linked whole
cell lysates, containing either wild-type or α5-helix-
deleted 14-3-3ε protein, were normalized to 20 μg/μl and
200 μl were immunoprecipitated with anti-14-3-3ε anti-
body or NRS. The immunoprecipitated chromatin
obtained in each ChIP assay was then quantified by Real-
time PCR, using the regions indicated above as template
DNA and the specific primers for amplifying each region
(see table 1). The quantity of PCR product from each tem-
plate is calculated at the threshold of amplification deter-
mined by the light-cycler software (Roche) by comparison
to the values of the genomic standard curve. As shown in
Figure 5C, these values (histogram bars) represent the
amount of chromatin immunoprecipitated in each sam-
ple, reflecting the number of DNA molecules initially
used in the Real-time PCR reaction. The results indicated
that the association of 14-3-3ε with ARS307 and ARS1
decreased by approximately 40% in the mutant cells, an
effect that may be directly attributed to the deletion of the
α5-helix in 14-3-3ε, as it is the sole physiological differ-
ence between the wild-type and mutant cells. In contrast,
in the respective negative regions of ARS307 and ARS1
(Neg307 and R2.5 respectively), the amount of immuno-
precipitated DNA was not significantly different between
the wild-type and the mutant cells. These amounts were
also comparable to the number of molecules brought
down non-specifically by NRS in both cell types. Taken
together, these data suggest that 14-3-3ε binds specifically
to origins of replication in yeast, and that the decreased
association with origins in the mutant cells is likely a
direct effect of the deletion of the α5-helix in 14-3-3ε.BMC Molecular Biology 2007, 8:27 http://www.biomedcentral.com/1471-2199/8/27
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Effect of R18 on cruciform-binding activity Figure 4
Effect of R18 on cruciform-binding activity. Lysate was prepared from yeast cells expressing wild-type 14-3-3ε as 
described in Methods under the WCE preparation section. A- Total protein extract (1 mg) was incubated at 30°C for 30 min 
in the absence or presence of 100 μM of R18 peptide, followed by immunoprecipitation with anti 14-3-3ε antibody and blotted 
with anti-Ras2 antibody. Immunoprecipitation with normal rabbit serum (NRS) and a Bmh1/2-expressing strain were used as 
controls. B- 14-3-3ε protein extracts were incubated in the same conditions as in section A with increasing amounts (10, 50 
and 100 μM) of R18, and then subjected to a cruciform binding assay, as described previously (see Methods). Free cruciform 
DNA denotes the position of the probe alone.
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Plasmid stability assay
DNA cruciforms have been implicated in the initiation of
DNA replication by acting as regulatory signals at origin
sites at the onset of S-phase (reviewed in [2]). Further-
more, 14-3-3 proteins have higher cruciform binding
(CBP) [2] and origin association [19] activities at the G1/
S boundary. In view of these observations, and in order to
test the hypothesis that 14-3-3 is a regulatory protein at
the initiation level of DNA replication, we analyzed
whether deletion of the α5-helix in 14-3-3ε affected the
maintenance and initiation of DNA replication of mini-
chromosomes (ARS-containing plasmids). In S. cerevisiae,
characterization of ARS function was largely done by
using a plasmid stability assay [40,41].
Here, the wild type (14-3-3ε) and the mutant (14-3-3-α5)
yeast strains were used to measure plasmid loss rates,
using a pair of test plasmids, containing either a single
Chromatin immunoprecipitation assays Figure 5
Chromatin immunoprecipitation assays. A-Formaldehyde cross-linked WCEs were immunoprecipitated with anti-14-3-
3ε antibody. Approximately the same amount of wild type and mutant 14-3-3ε were revealed by the anti-14-3-3ε antibody. 
NRS and 14-3-3ε WCE were used as controls for the IP. B- The immunoprecipitated chromatins were subjected to conven-
tional PCR and resolved in a 1.5% agarose gel. Upper panel of the gel shows the PCR products of the ChIP performed with 
wild-type 14-3-3ε extracts (arrow). The lower panel shows the PCR products of the ChIP performed with α5-helix-deleted 
14-3-3ε extracts (arrow). Template DNAs from reverse cross-linked cells immunoprecipitated with anti-14-3-3ε antibody 
(lane 1) or pre-immune sera (lane 2), wild-type and mutant yeast WCE (lane 3 in upper and lower panel respectively); 10 ng of 
genomic DNA (lane 4) and 10 ng of plasmid pRS306 containing ARS307 (line 5), were used as controls. C- The amounts of 
wild-type or α5-deleted 14-3-3ε proteins associated with ARS307, ARS1 and their negative regions, Neg307 and R2.5 respec-
tively, were measured by Real-time PCR. Cross-linked WCE were immunoprecipitated using anti-14-3-3ε antibody or NRS, 
and each corresponding ChIP material was used as template DNA. Error bars represent the average of three separate experi-
ments and one standard deviation.
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ARS, pARS-1 (containing ARSH4) or two, pARS-2 (con-
taining ARSH4 and ARS307) (see Methods). In all the pre-
viously characterized mutants of proteins involved in the
initiation of DNA replication, such as ORC, Cdc6, MCM,
and Cdc45, plasmids containing a single replication ori-
gin had higher plasmid loss rates than plasmids contain-
ing multiple replication origins, while wild-type cells lost
both test plasmids at equally low rates [42,43].
As shown in Figure 6, deletion of the α5-helix in 14-3-3ε
compromised the mutant cells, containing 14-3-3ε-α5
protein, in their maintenance of the minichromosome
pARS-1, showing a plasmid loss rate of approximately 5%
per generation. In contrast, when pARS-2 was expressed in
these cells, the plasmid was more stable by approximately
2.5-fold. When the same assay was performed using wild-
type cells, both test plasmids were lost at a much lower
rate of approximately 1–1.4% per generation. These
results indicated that the deletion of the α5-helix in 14-3-
3ε was responsible for the higher plasmid loss rate, sug-
gesting that this protein regulates DNA replication at the
initiation level.
Discussion
In the present study, we analyzed the effect of deleting the
α5-helix domain of 14-3-3ε on its cruciform binding and
replication origin binding activities as well as on the initi-
ation of DNA replication. The results show that the
human 14-3-3ε protein can replace its counterparts,
Bmh1 and Bmh2, in S. cerevisiae, as yeast cells expressing
only human 14-3-3ε were viable. Previous studies have
shown that the human cruciform binding protein CBP/
14-3-3 associates in vitro with cruciform-containing DNA
[13] as well as in vivo with mammalian origins of DNA
replication [19]. The Bmh1 and Bmh2 proteins have been
shown to have the same activities as their mammalian
homologues, namely the 14-3-3 proteins [4]. CBP associ-
ation with cruciform DNA occurs only in the dimeric form
of the protein [8], mainly in a heterodimeric conforma-
tion with a preferential pattern of heterodimerization
[44]. Furthermore, using different genetic backgrounds of
yeast, it was previously shown that the Bmh1-Bmh2 het-
erodimer was more efficient in binding to cruciform DNA
than the homodimer of either protein [4]. Here, we have
shown that the human 14-3-3ε expressed in yeast con-
serves its cruciform binding activity, indicating that it can
dimerize with itself and functions as a homodimer. Previ-
ous studies on dimer profile analysis reported that endog-
enous 14-3-3ε isoform was never found as a homodimer
[45,46]. This discrepancy may be explained by the prefer-
ential pattern of dimers adopted in mammalian cells,
which is not afforded in the yeast strains used in this
study. Furthermore, it was previously shown that the 14-
3-3 plant homologue GF14 was also able to homodimer-
ize and binds to cruciform DNA [4].
Although the mode of association of CBP/14-3-3 with
cruciform DNA has been previously shown [13], the
regions of 14-3-3 responsible for this activity have not
been determined yet. Thus, hydroxyl radical footprinting
analyses showed that CBP binds to cruciform DNA at the
four-way junction [13], as does the anti-cruciform anti-
body, 2D3 [16]. Taken together, these results suggested
the involvement of a common domain(s) between CBP/
14-3-3 protein and 2D3 antibody responsible for CBP
activity. Alignment of 14-3-3ε and 2D3 amino acid
Table 1: Sequences of primers used for the constructs and the LightCycler
Primers Sequences
α5-helix deletion
Fragment 1-F 5' CGGAATTCATGGATGATCCGAGAGGATCTG 3'
Fragment 2-F 5' GCTCTAGATCACTGATTTTCGTCTTCCAC 3'
Fragment 1-R 5' CGCCTTGGACTCGCCAGTGTTAGCTGC 3'
Fragment 2-R 5' GCCCAAGGCCACAGGAAACGACAGGAAGG 3'
PCR of ARS307
ARS307-F 5' ATATTGCAATTACTTCTTCTCATGCAC 3'
ARS307-R 5' ATATTGCAATTACTTCTTCTCATGCAC 3'
PARS307-F 5' GGTAGGGATAATAATCTGTAATGAGGA 3'
PARS307-R 5' TATGTCGACGAGTGAGTTGGA 3'
Real-Time PCR
RT-ARS307-F 5' GCAGTAGCACATGGACACATTCAC 3'
RT-ARS307-R 5' AGGGTTTCTGGAGAGGTAGGGATA 3'
NegARS307-F 5' ATTTTGTGGTGGATTGGAG 3'
NegARS307-R 5' GCTTGTTTGTGCAACTAAACG 3'
ARS1-F 5' GAAAATAGGTTATTACTGAGTAG 3'
ARS1-R 5' CCTGCGATGTATATTTTCCTG 3'
R2.5-F 5' CATCAATTGTGCACTCGGAC 3'
R2.5-R 5' GAACACGGCAATTGTAGGTGG 3'BMC Molecular Biology 2007, 8:27 http://www.biomedcentral.com/1471-2199/8/27
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sequences revealed a 23% identical (40% identical when
positive charges residues are taken in account) region, cor-
responding to the α5-domain in 14-3-3ε protein (amino
acids 119–169). Crystallography of 14-3-3 protein
showed that the molecule is a cup-shaped dimer [14,15].
Each monomer contains nine α-helices (denoted α1-α9),
with the dimer interface formed from helices α1, α3 and
α4, while helices α5-α9 form an amphipathic groove that
is considered as the binding domain of the protein [17].
This information argued strongly for a possible involve-
ment of the 14-3-3 α5-domain in cruciform binding activ-
ity and regulation of DNA replication, and prompted the
analysis of the effects of its deletion on these processes.
As shown above, although both the wild-type and α5-
deleted 14-3-3ε were able to bind cruciform DNA, the
DNA-protein complex formed with the mutant protein
exhibited a lower band-shift than the one formed with the
wild-type, indicating an inhibitory effect of the α5-dele-
tion on the cruciform binding (CBP) activity. The α5-
domain, however, seemingly participates partially in this
activity, since its deletion did not completely abolish CBP
activity. Considering that 14-3-3 binds to cruciform DNA
in a structure-specific manner [7], the domains adjacent to
the α5-helix might contribute to its full activity, as it is the
case for the interactions of 14-3-3 with other proteins
[17]. Alternatively, the difference in the cruciform mobil-
ity-shift might be due to changes in the conformation of
the cruciform DNA molecule upon binding to the mutant
protein. It was shown previously that CBP/14-3-3 binding
can cause structural alterations in the DNA, thereby pre-
senting the appropriate signals for DNA replication [13].
The band-shift patterns obtained in this study may have
arisen because the mutated 14-3-3ε might not be able to
induce the proper structural alterations in the cruciform
forming within the origin, which may either result in a
less stable cruciform or alter the ability of other proteins
to bind to the origin. Cruciform stabilization at replica-
tion origins has been shown to be induced by the anti-cru-
ciform DNA antibody, 2D3 [1].
14-3-3 proteins associate in vivo with replication origins in
mammalian [18] and yeast [4] cells. In this study, we
showed for the first time that a human 14-3-3ε was able
to bind specifically to active yeast origins of replication,
ARS307 and ARS1, while deletion of the α5-helix in 14-3-
3ε decreased its association with these origins. The
sequence requirements for replication origin activity vary
considerably between different eukaryotic organisms. In
S. cerevisiae, these sequences consist of an essential A ele-
ment, containing the ARS consensus sequence (ACS) [47]
and two or three important B elements that are collec-
tively required for origin function [40]. Initiation of repli-
cation requires the presence of ACS, which together with
the B1 element forms the binding site of the origin recog-
nition complex (ORC) [48]. ORC remains stably bound
to the chromatin throughout the cell cycle [49], and
recruits other proteins to the origin in a cell cycle regu-
lated manner [50]. In higher eukaryotes, the molecular
basis of origin identity and function is less well under-
stood. Indeed, the cis-acting sequences required to direct
the initiation of DNA replication are more complex and
may extend over thousands of base pairs of DNA in mam-
malian origins [51]. Like in S. cerevisiae, these sequences
direct the formation of a number of protein complexes
leading to the assembly of the pre-replicative complex
(pre-RC) at origins during G1 [30]. These proteins
include, among others that are conserved, ORC homo-
logues that have been identified in all eukaryotes [52].
The sequence preference for ORC binding is not absolute
in metazoa, suggesting that there may be other factors that
increase the affinity of ORC binding to origins [53]. These
factors include proteins such as the recently identified ini-
tiator protein OBA/Ku86 [54]. Although there is no appar-
ent sequence homology between mammalian and yeast
origins, previous studies as well as the data here suggest
that 14-3-3 binds to a common structural feature in these
different origins, namely cruciform DNA. Furthermore,
considering that 14-3-3 is a cruciform binding protein,
and the fact that several isoforms of this protein have been
immunoprecipitated with cruciform structures present in
mammalian and yeast replicators [4], it may be concluded
that 14-3-3 proteins bind to active yeast and mammalian
origins at cruciform structures.
Plasmid stability assay Figure 6
Plasmid stability assay. Plasmid loss rates were measured 
for the wild-type and α5-deleted 14-3-3ε yeast cells contain-
ing either pARS-1 or pARS-2. Plasmid loss rates are 
expressed as the average of percent loss per generation. 
Error bars represent the average of three separate experi-
ments and one standard deviation.BMC Molecular Biology 2007, 8:27 http://www.biomedcentral.com/1471-2199/8/27
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In this study, we have also identified 14-3-3 as a novel ini-
tiator protein for yeast DNA replication. 14-3-3 proteins
are known to be important regulators of vital cellular
functions such as transcription, cell cycle control and sig-
nal transduction. It is thus reasonable to assume that the
replication initiation phenotypes of the α5-helix-deleted
14-3-3ε might be the indirect result of an aberrant tran-
scription or regulation of other initiator proteins. The role
of 14-3-3 in the regulation of transcription in S. cerevisiae
has been recently investigated, using a bmh2-ts mutant
[33]. That study revealed that the yeast 14-3-3 homo-
logues stimulate the transcription of many genes involved
in ergosterol metabolism and in stress response, but
found no alteration in the transcription of initiator pro-
teins like ORC, Cdc6 or MCM proteins. 14-3-3 has also
been shown to regulate the transcription of inducible
genes by regulating the function of the histone H3 protein
[55]. However, the association of 14-3-3 with DNA bound
to histone H3 cannot explain the decrease of the associa-
tion of the mutant 14-3-3 with the origin in this study,
because the region of the chromosome that is affected is
limited to origin containing DNA. Furthermore, the asso-
ciation between 14-3-3 and histone proteins is not sys-
tematic. In a recent study, a GINS complex responsible for
fork progression during DNA synthesis was purified [56]
and found to contain the four histone proteins but no 14-
3-3. In general, the notion that 14-3-3 may play an indi-
rect role in replication by controlling transcription or even
protein-protein interactions would be incompatible with
the fact that 14-3-3 physically interacts with replication
origins, as shown previously [19] and here by the ChIP
assay. Furthermore, the data in this study indicate that 14-
3-3ε plays a direct role in the initiation of DNA replica-
tion, as it is required for the maintenance of a minichro-
mosome, as assayed by plasmid loss rate of two ARS-
containing plasmids. This assay can reveal whether a
mutant is likely defective in the initiation of DNA replica-
tion [42].
Lottersberger and co-workers [29] showed in a recent
study that some bmh1-ts mutants had growth defects,
which may be related to a low expression of G1 cyclin-
cdk1. They attributed the cell cycle arrest to a decrease in
the level of CLN2 protein (one of Cdk1 subunits) in the
bmh1 mutants, where there was a complete G1/S arrest
after shifting to 37°C. This statement was not necessarily
true for the other mutants used in the same study, where
the G1/S transition was only delayed. In our study, we
observed a slow growth in the 14-3-3ε-α5 protein express-
ing cells. This growth defect is most likely not attributable
to a lower expression of the G1 cyclin-cdk1, since our
mutant cells are not temperature sensitive and do not rep-
resent any noticeable difference in the cell cycle distribu-
tion in log phase (data not shown). Rather, it might be
explained, at least in part, by the results from the plasmid
stability assays, given the extent of the loss viability
observed in the mutant cells. This assay indicates that the
mutation in 14-3-3ε is affecting the initiation of DNA rep-
lication most likely by disrupting its direct association
with origins of replications sites. Nevertheless, given the
effect of 14-3-3 proteins on different regulatory processes,
such as transcription and cell cycle progression, it is possi-
ble that other mechanisms also contribute to this growth
defect.
Conclusion
Overall, the data presented here attest to the universality
of binding of 14-3-3 proteins to replication origins and
their involvement in the regulation of DNA replication.
Our data, coupled with the apparent function of 14-3-3
proteins in the G1/S transition [19], and the role of cruci-
form DNA in the initiation of replication [1], suggest that
14-3-3 may function in the initiation of DNA replication
by regulating the formation or maintenance of the pre-RC
through interactions with cruciform DNA. To elucidate
the exact mechanism of this process, the association of 14-
3-3 with other initiator proteins, as well as the cell cycle
profile and regulation of these proteins in budding yeast
are currently being investigated.
Methods
Strains, plasmids and constructs
The yeast strain GG1259 (haploid leu2-3,112 ura3-52 trp1-
92 bmh1::LEU2 bmh2::URA3 his4 pYES-TRP(GF14); a gen-
erous gift from Dr. G. P. H. van Heusden, Leiden Univer-
sity, The Netherlands) was used. The strain was modified
by disrupting the URA cassette and selected by 5-
fluoroorotic acid, 5-FoA (Wako Pure Chemicals, Osaka,
Japan), and used as a host for the transformation by
pEVP11 plasmid [57] bearing either wild-type or mutant
14-3-3ε cDNAs. pEVP11 contains the ADH promoter and
has uracil as a selection maker. pYES(GF14) plasmid, ini-
tially present to rescue the bmh1-bmh2 double knockout,
was shuffled from the cells. The resulting new strains
expressing 14-3-3ε or 14-3-3ε-α5 proteins were used as
genetic backgrounds for the rest of the experiments. YPD
and complete minimal dropout medium with a further
addition of the specific nutrient requirement were used
when mentioned. All cell cultures were grown at 30°C.
Test plasmids-pARS-1 and pARS-2
The episomal plasmid pRS313-HIS3 contains ARSH4 as a
yeast origin of replication. It has been used without any
modifications as test plasmid pARS-1, or modified by the
insertion of ARS307 sequence to construct the test plas-
mid pARS-2. pARS-2 was constructed by cloning, in the
pRS313 multiple cloning site, a 365 bp EcoRI-SalI ARS307
fragment which was initially amplified from the pRS306
plasmid bearing the ARS307 sequence (a gift from Dr. C S
Newlon, Univ. of New Jersey Medical School). The PCRBMC Molecular Biology 2007, 8:27 http://www.biomedcentral.com/1471-2199/8/27
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amplification of this fragment was done by using the
PARS307 primers (Tab. 1). Successful cloning of the
ARS307 fragment in pARS-2 was verified by sequencing.
Deletion of the α5 domain in 14-3-3 epsilon protein
Full-length human 14-3-3ε cDNA (a gift from Dr. A.
Aitken, Univ. of Edinburgh) was used as template DNA to
construct the deleted protein. Deletion of the α-5 helix of
14-3-3ε was produced by polymerase chain reaction
(PCR) amplification of two fragments, both lacking the
60 bp sequence DNA of the α-5 helix. The primers used to
make this deletion are listed in Table 1. Both fragments
were digested with StyI restriction enzyme, followed by
ligation. Wild-type and mutant PCR products were cloned
separately into plasmid pEVP11 and the corresponding
DNA sequences were verified by sequencing. The resulting
plasmids were then used to transform yeast GG1259 cells
by the lithium acetate procedure.
Whole cell extract and western blotting
Cells were bead-beaten in lysis buffer (50 mM Tris, pH
7.5, 0.1% Triton X-100, 100 mM NaCl, 2.0 mM EDTA, 2.0
mM phenylmethylsulfonyl fluoride, 2.0 mM Sodium
orthovanadate (Na3VO4), and 20 mM EGTA, 50 mM
NaF), supplemented with 1 pill of protease inhibitors
(Roche Molecular Biochemicals) before use. Lysate free of
beads was microcentrifuged at maximum speed for 5 min-
utes at 4°C. The supernatant was mixed with equal vol-
ume of 2× protein sample buffer containing 100 mM
dithiothreitol, and the samples were loaded onto a 12%
SDS-polyacrylamide gel. Electrophoresis was carried out
at 120 V for 90 minutes, and the gel contents were subse-
quently transferred onto Immobilon™ P transfer mem-
brane. Immunoblotting was done by using anti-14-3-3ε
antibody (T16) (Santa Cruz Biotechnology), anti-Bmh1
antibody (a gift from Dr van Heusden, Netherlands), and
anti-Ras2 antibody (yC-19) (Santa Cruz Biotechnology).
Electromobility-shift assay
Band-shift assays
Cruciform-containing DNA was constructed and end-
labelled as described previously [7]. 20 μg of wild-type or
mutant whole cell extracts (WCE) were incubated with ~3
ng of labelled cruciform DNA for 30 minutes on ice in
binding buffer, as previously described [7]. The mixtures
were subjected to 4% polyacrylamide gel electrophoresis
(PAGE) at 180 V for 2 h. The gel was dried and exposed for
autoradiography. R18 experiment was done as described
previously [38] prior to the mobility shift assay. 20 μg of
wild type 14-3-3ε yeast extract was incubated without or
with increasing amounts (10, 50 and 100 μM) of R18
(Biomol International, LP) for 30 minutes at 30°C. Cruci-
form binding assay reagents were added and incubated on
ice for 30 minutes before loading on the gel as described
above.
Band-shift elution and immunoblotting
Wild-type and α5-deleted 14-3-3ε proteins were purified
as previously described [8] with some modifications. In
brief, 300 ng of labelled cruciform DNA [7] was used for
binding either wild-type or mutant 14-3-3ε from 100 μg
of their respective WCEs. Cruciform-protein complexes
were subjected to PAGE in a 4% polyacrylamide gel at 180
V for 1.5 h. Each complex was eluted from the gel by iso-
tachophoresis, as previously described [8]. Eluates were
concentrated to 3 μg/μl with Microcon YM-10 concentra-
tor (Millipore Corp.). Then, 30 μg of each band shift-
eluted preparation were mixed with 1 × SDS sample buffer
containing 100 mM dithiothreitol, and the samples were
subjected to PAGE in a 12% SDS-polyacrylamide gel. The
gel contents were transferred into Immobilon™ P transfer
membrane, which was probed with anti-14-3-3ε antibody
(T16) (Santa Cruz Biotechnology).
Chromatin immunoprecipitation (ChIP) assay
in vivo cross-linking
In vivo cross-linking was carried out essentially as previ-
ously described [58]. In brief, 50 ml of wild-type and
mutant cells were grown in YPD to A595 = 0.8–1.0. Cells
were crosslinked with 1% formaldehyde and incubated
for 1 hour at room temperature with gentle shaking. Cells
were harvested by centrifugation at 1000 × g at 4°C for 15
minutes, the pellets were washed twice with ice-cold PBS,
and then once with buffer I (50 mM Hepes/KOH (pH
7.5), 140 mM NaCl, 1 mM EDTA (pH 7.5), 1% (v/v) Tri-
ton X-100, and 0.1% (w/v) sodium deoxycholate).
Preparation of whole cell extracts
Pellets from cross-linked cells were resuspended in 250 μl
of ice-cold buffer I containing protease inhibitors (1 mM
phenylmethylsulfonyl fluoride and one tablet of protease
inhibitors (Roche Molecular Biochemicals). The cell sus-
pensions were lysed by bead-beating for 30 seconds and
then chilled on ice for another 30 seconds for eight cycles.
Beads were discarded and the lysates were sonicated for 15
seconds eight times, with 30 seconds intervals on ice
between each pulse to chill the samples. After centrifuga-
tion at 14,000 rpm for 15 minutes at 4°C, protein concen-
trations of all samples were normalized with ice-cold
buffer I. An aliquot of this supernatant served as the whole
cell extract (WCE).
Immunoprecipitation and DNA isolation
2 mg total proteins of the WCE was precleared with 50 μl
of protein G-agarose (Roche Molecular Biochemicals) for
1 h at 4°C and then incubated at 4°C for 12 h with 10 μl
of either preimmune serum or 5 μg of anti-14-3-3ε anti-
body (Santa Cruz biotechnology). 50 μl of protein G-aga-
rose was added, and the incubation was continued for 2
h. The precipitates were successively washed twice for 5
minutes at 4°C with 1 ml of each of the following buffers:BMC Molecular Biology 2007, 8:27 http://www.biomedcentral.com/1471-2199/8/27
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ice-cold buffer I, ice-cold buffer II (50 mM Hepes/KOH
(pH 7.5), 500 mM NaCl, 1 mM EDTA (pH 7.5), 1% (v/v)
Triton X-100, and 1% (w/v) sodium deoxycholate); ice-
cold buffer III (10 mM Tris-Cl (pH 8.0), 250 mM LiCl, 1
mM EDTA (pH 7.5), 0.5% (v/v) Nonidet P-40, and 0.5%
(w/v) sodium deoxycholate); and ice-cold Tris/EDTA
buffer (pH 7.6). Finally, the pellets were resuspended in
200 μl of extraction buffer (1% SDS/Tris/EDTA buffer).
Samples were then incubated at 65°C overnight to reverse
the protein-DNA cross-links, followed by 2 h incubation
at 37°C with 50 μg of proteinase K (Roche Molecular Bio-
chemicals). At the end, samples were processed to purify
the DNA by passing them through QIAquick PCR purifi-
cation columns (QIAGEN Inc., Valencia, CA).
PCR amplification of the co-immunoprecipitated DNA
The immunoprecipitated materials, WCE and genomic
DNA, were used as templates in conventional PCR with
Ready-To-Go PCR beads (Amersham Biosciences). Prim-
ers ARS307 (1 μM each; GENSETCorp.) (Tab. 1) were
used to amplify a 370-bp DNA fragment from the yeast
autonomous replication sequence ARS307 (GenBank™/
EBI accession number X04219). An initial denaturation
for 5 minutes at 94°C was followed by 35 cycles of dena-
turing for 30 seconds at 94°C, annealing for 30 seconds at
50°C, polymerization for 1 minute at 72°C, and a final
extension for 10 minutes at 72°C. PCR products were sep-
arated on 1.5% agarose gel, visualized with ethidium bro-
mide, and photographed with an Eagle Eye apparatus
(Speed Light/BT Sciencetech-LT1000).
Real-time PCR amplification of the co-immunoprecipitated DNA
PCR reactions were carried out in 20 μl with one-two hun-
dredth of the immunoprecipitated material, using Light-
Cycler capillaries (Roche Molecular Biochemicals).
Specific primers for the Real-time PCR (listed in Table 1)
were added at 1 μM concentration. Genomic DNA was
used to generate the standard curve. For the Real-time PCR
reactions, an initial denaturation for 5 minutes at 95°C
was followed by 35 cycles with denaturation for 15 sec-
onds at 95°C; the annealing temperatures were used
according to different fragments amplified (ARS307,
Neg307, ARS1 or R2.5) for 10 seconds, followed by
polymerization for 10 seconds at 72°C. The specificity of
the amplified PCR products was assessed by performing a
melting curve analysis after the PCR amplification.
Plasmid stability assay
The assay was performed as described [59]. pARS-1 and
pARS-2 were used separately to transform both wild type
and mutant 14-3-3ε yeast strains, using the standard lith-
ium acetate method. Cells were then grown to early log-
phase in selective medium, SCM-His. The cultures were
diluted to 2 105 cells/ml in YPD and grown for 10 genera-
tions. Equal amounts of cells were then plated on YPD
and SCM-His plates, and plasmid loss rates were deter-
mined by counting colonies before and after incubation
in YPD media. The stability value for each plasmid is an
average of three independent experiments, each using col-
onies from a separate transformation.
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